Wegovy begins to act in the body after the first injection, and some individuals may notice more pronounced side effects early on as the body adapts
Patients with these conditions should discuss their medical history with their healthcare providers before starting GLP-1 therapy
Contact your doctor if you experience new or worsening cognitive symptoms after starting GLP-1 therapy, especially if accompanied by severe nausea, dehydration, or signs of hypoglycemia
The medication exits your system quickly, and no evidence suggests lasting harm to an early pregnancy
Clinical support is available at no additional charge for dosage questions or adjustments
Hyperkalemia and its association with mortality, cardiovascular events, hospitalizations, and intensive care unit admissions in a population-based retrospective cohort